TCRR - TCR2 Therapeutics' (TCRR) CEO Garry Menzel on Q1 2019 Results - Earnings Call Transcript
TCR2 Therapeutics Inc. (TCRR)
Q1 2019 Earnings Conference Call
May 13, 2019 5:30 PM ET
Company Participants
Carl Mauch – Director-Investor Relations and Corporate Communications
Garry Menzel – Chief Executive Officer
Alfonso Quintás – Chief Medical Officer
Ian Somaiya – Chief Financial Officer
Robert Hofmeister – Chief Scientific Officer
Conference Call Participants
Biren Amin – Jefferies
Jonathan Chang – SVB Leerink
Do Kim – BMO Capital Markets
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the TCR2' First Quarter 2019 Earnings Conference Call. As a reminder, this conference call maybe recorded. I would